Skip to main content

Cofactor Genomics, Novocraft Technologies Partner in Southeast Asia

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The sequencing service provider Cofactor Genomics and the bioinformatics company Novocraft Technologies plan to partner to offer sequencing and analysis services in Southeast Asia, Cofactor announced today.

Through the partnership, St. Louis-based Cofactor will offer sequencing services in Southeast Asia and Kuala Lumpur-based Novocraft will provide analyses to support this sequencing effort.

Cofactor, which launched in 2008, uses Illumina and Applied Biosystems sequencing technology combined with commercial and proprietary analysis software, while Novocraft develops novel algorithms for analyzing high throughput sequencing data.

"Southeast Asia is an important emerging market for genome sequencing and analysis and Novocraft's influence in that region will play a fundamental role in helping Cofactor reach our goals," Jon Armstrong, chief marketing officer for Cofactor, said in a statement, noting that the company is already using some Novocraft tools in-house.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.